Search Results

There are 7920 results for: content related to: In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species

  1. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 3, June 2012, Pages: 319–327, N. Suksomboon, N. Poolsup and T. Prasit

    Version of Record online : 17 AUG 2011, DOI: 10.1111/j.1365-2710.2011.01295.x

  2. Pharmacokinetic-pharmacodynamic model of the antihypertensive interaction between telmisartan and hydrochlorothiazide in spontaneously hypertensive rats

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 8, August 2014, Pages: 1112–1121, Kun Hao, Yuancheng Chen, Xiaoping Zhao and Xiaoquan Liu

    Version of Record online : 17 MAR 2014, DOI: 10.1111/jphp.12230

  3. You have free access to this content
    Chronic blockade of angiotensin AT1receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats

    British Journal of Pharmacology

    Volume 171, Issue 3, February 2014, Pages: 746–760, Helge Müller-Fielitz, Nils Hübel, Martin Mildner, Florian M Vogt, Jörg Barkhausen and Walter Raasch

    Version of Record online : 13 JAN 2014, DOI: 10.1111/bph.12510

  4. You have free access to this content
    Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats

    British Journal of Pharmacology

    Volume 172, Issue 3, February 2015, Pages: 857–868, Helge Müller-Fielitz, Margot Lau, Cathleen Geißler, Lars Werner, Martina Winkler and Walter Raasch

    Version of Record online : 24 NOV 2014, DOI: 10.1111/bph.12949

  5. Pharmacokinetics of Oral Doses of Telmisartan and Nisoldipine, Given Alone and in Combination, in Patients With Essential Hypertension

    The Journal of Clinical Pharmacology

    Volume 47, Issue 3, March 2007, Pages: 295–304, Milica Bajcetic, Ralf A. Benndorf, Daniel Appel, Edzard Schwedhelm, Friedrich Schulze, Daniel Riekhof, Renke Maas and Rainer H. Böger

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006297225

  6. Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 6, June 2015, Pages: 671–679, Xuesong Su, Rui Yu, Xu Yang, Guangyu Zhou, Yanqiu Wang, Li Li and Detian Li

    Version of Record online : 4 JUN 2015, DOI: 10.1111/1440-1681.12403

  7. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 6, June 2011, Pages: 533–541, S. N. Goyal, S. Bharti, J. Bhatia, T. C. Nag, R. Ray and D. S. Arya

    Version of Record online : 20 APR 2011, DOI: 10.1111/j.1463-1326.2011.01377.x

  8. You have full text access to this OnlineOpen article
    The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1

    Pharmacology Research & Perspectives

    Volume 3, Issue 4, August 2015, Lasse Saaby, Peer Tfelt-Hansen and Birger Brodin

    Version of Record online : 11 JUN 2015, DOI: 10.1002/prp2.151

  9. You have full text access to this Open Access content
    Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 6b, June 2010, Pages: 1645–1656, Martin Steinmetz, Caroline Brouwers, Georg Nickenig and Sven Wassmann

    Version of Record online : 23 JUN 2009, DOI: 10.1111/j.1582-4934.2009.00829.x

  10. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients

    Journal of Clinical Pharmacy and Therapeutics

    Volume 34, Issue 6, December 2009, Pages: 683–692, M. Miura, S. Satoh, H. Kagaya, M. Saito, T. Inoue, T. Ohkubo, T. Habuchi and T. Suzuki

    Version of Record online : 1 JUL 2009, DOI: 10.1111/j.1365-2710.2009.01053.x

  11. You have free access to this content
    Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor

    British Journal of Pharmacology

    Volume 151, Issue 7, August 2007, Pages: 952–962, M T Le, M K Pugsley, G Vauquelin and I Van Liefde

    Version of Record online : 17 FEB 2009, DOI: 10.1038/sj.bjp.0707323

  12. The pharmacokinetic–pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive rats

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 6, December 2015, Pages: 543–552, Dan Yu, Yuancheng Chen and Kun Hao

    Version of Record online : 5 OCT 2015, DOI: 10.1111/fcp.12152

  13. Telmisartan prevents angiotensin II-induced endothelial dysfunction in rabbit aorta via activating HGF/Met system and PPARγ pathway

    Fundamental & Clinical Pharmacology

    Volume 28, Issue 5, October 2014, Pages: 501–511, Ze-Ping Hu, Xiao-Ling Fang, Hai-Yan Qian, Nan Fang, Bang-Ning Wang and Yuan Wang

    Version of Record online : 29 NOV 2013, DOI: 10.1111/fcp.12057

  14. Ligand-supported homology modeling of the human angiotensin II type 1 (AT1) receptor: Insights into the molecular determinants of telmisartan binding

    Proteins: Structure, Function, and Bioinformatics

    Volume 65, Issue 4, 1 December 2006, Pages: 824–842, Akshay Patny, Prashant V. Desai and Mitchell A. Avery

    Version of Record online : 10 OCT 2006, DOI: 10.1002/prot.21196

  15. Economic evaluation of telmisartan, valsartan and losartan in combination with hydrochlorothiazide for treatment of mild-to-moderate hypertension in Greece: a cost-utility analysis

    Journal of Pharmaceutical Health Services Research

    Volume 4, Issue 2, June 2013, Pages: 81–88, Georgia Kourlaba, Vassilios Fragoulakis, Dorina Theodoratou and Nikos Maniadakis

    Version of Record online : 4 APR 2013, DOI: 10.1111/jphs.12014

  16. Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in zucker diabetic fatty rats with metabolic syndrome

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 4, April 2012, Pages: 320–328, B. Rinaldi, C. Di Filippo, A. Capuano, M. Donniacuo, L. Sodano, F. Ferraraccio, F. Rossi and M. D'Amico

    Version of Record online : 2 DEC 2011, DOI: 10.1111/j.1463-1326.2011.01527.x

  17. You have free access to this content
    A Review on Telmisartan: A Novel, Long-Acting Angiotensin II-Receptor Antagonist

    Cardiovascular Drug Reviews

    Volume 18, Issue 2, June 2000, Pages: 127–154, Wolfgang Wienen, Michael Entzeroth, Jacobus C. A. van Meel, Joachim Stangier, Ulrich Busch, Thomas Ebner, Jochen Schmid, Horst Lehmann, Kandace Matzek, Joan Kempthorne-Rawson, Volker Gladigau and Norbert H. Hauel

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2000.tb00039.x

  18. Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease

    Geriatrics & Gerontology International

    Volume 12, Issue 2, April 2012, Pages: 207–214, Kazumasa Kume, Haruo Hanyu, Hirofumi Sakurai, Yusuke Takada, Takeshi Onuma and Toshihiko Iwamoto

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1447-0594.2011.00746.x

  19. Dose Response and Safety of Telmisartan in Patients with Mild to Moderate Hypertension

    The Journal of Clinical Pharmacology

    Volume 40, Issue 12, December 2000, Pages: 1380–1390, Dr. David H. G. Smith, Ms. Kandace M. Matzek and Dr. Joan Kempthorne-Rawson

    Version of Record online : 19 MAR 2013, DOI: 10.1177/009127000004001210

  20. Pharmacokinetics and Safety of Intravenous and Oral Telmisartan 20 mg and 120 mg in Subjects with Hepatic Impairment Compared with Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 40, Issue 12, December 2000, Pages: 1355–1364, Dr. Joachim Stangier, Dr. Chung-An P. F. Su, Dr. G. Schöndorfer and Dr. Willy Roth

    Version of Record online : 19 MAR 2013, DOI: 10.1177/009127000004001207